Chronic myelogenous leukemia (CML) is a disease of the hematopoietic stem cell, characterized by the t(9 ; 22) q(34 ; q11) translocation encoding the oncoprotein BCR-ABL [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.